Real-time enrollment status for this renal cell carcinoma (rcc) clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 3:04 AM UTC
| NCT Number | NCT05176483 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma (RCC) |
| Phase | PHASE1 |
| Target Enrollment | 1,394 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Exelixis |
| Last Updated on CT.gov | October 1, 2026 (1 week ago) |
As of October 13, 2026: Clinical trial NCT05176483 is currently recruiting participants. This phase1 study for renal cell carcinoma (rcc) is actively seeking new participants at 46 locations across the United States. The study is sponsored by Exelixis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05176483 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05176483 was last updated 1 week ago (October 1, 2026). HelloStudys verifies this status automatically.